Seller positioningFormula logicFinished-product evidence vs ingredient evidenceFDA claim categories matterPractical interpretation
Seller positioning
The current label uses structure/function wording around normal prostate function, urinary-system support and bladder control support. Those statements are different from saying that a supplement treats benign prostatic hyperplasia, infection, urinary retention or cancer.
Formula logic
The formula combines iodine, seaweed-derived ingredients, saw palmetto, neem, pomegranate and shilajit. Some of these ingredients have nutritional or traditional-use contexts, but that does not establish a single validated “mechanism” for the finished product.
Finished-product evidence vs ingredient evidence
To call a finished supplement clinically proven, we would want controlled studies on that exact finished formula at the actual serving dose. We have not identified such evidence in the materials supplied for this build. Ingredient studies should therefore be discussed as ingredient studies.
FDA claim categories matter
FDA distinguishes structure/function claims from disease claims. A dietary supplement may describe support for normal structure or function when substantiated, but it should not be presented as diagnosing, treating, curing or preventing a disease.
Practical interpretation
If you are considering Prostadine, evaluate it as a dietary supplement: read the label, review the iodine exposure, consider medication/condition interactions with a clinician, and do not delay evaluation of urinary symptoms.